First human tests begin for new poxvirus drug candidate
NCT ID NCT07377175
Summary
This is an early-stage study to check the safety and how the body processes a new drug called BSY001. It involves 76 healthy volunteers who will receive either the drug or a placebo. The main goal is to see how safe different doses are and how long the drug stays in the bloodstream, which is a first step for a potential future treatment for poxvirus infections like monkeypox.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONKEYPOX are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shulan (Hangzhou) Hospital
RECRUITINGHangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.